| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.09 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |